Venous

Top Story

The Take Home: ISET

The Take Home: ISET
February 18, 2020
Meeting News

VERNACULAR: Venous stent patency remains high at 2 years

February 10, 2020
Rates of patency and freedom from target lesion revascularization in patients receiving a venous stent were high at 2 years, according to new data from the VERNACULAR…
Meeting News

VIRTUS: Venous stent safe, effective at 24 months

February 9, 2020
Among patients with challenging venous lesions, a venous stent was associated with high rates of primary patency and freedom from major adverse events at 24 months…
Meeting News

DCB remains superior to PTA at 1 year in treatment of arteriovenous fistula lesions

February 6, 2020
A drug-coated balloon was superior to percutaneous transluminal angioplasty at 1 year for primary patency and clinically driven target lesion revascularization in…
More Headlines »
Cover Story

A Moving Target

Cardiology Today's Intervention, November/December 2018
The proliferation of novel catheter-directed therapies for pulmonary embolism and deep vein thrombosis has spurred…
More »
Video
Meeting News

VIDEO: ‘International crisis’ of PE at forefront of vascular intervention

February 19, 2019
More »
The Take Home

The Take Home: ISET

February 18, 2020
The International Symposium on Endovascular Therapy, held Jan. 22 to 25 in Hollywood, Florida, tackled many of the…
More »